Methods and formulations to reduce elevated levels of lipids and apolipoprotein B in subjects having type lIb hyperlipidemia. Methods for preventing, delaying or regressing complications of lipid disorders, including； type lIb hyperlipidemia, NAFLD, and NASH. Methods for preventing or delaying primary and secondary cardiovascular events. Kits useful for such methods. Methods for reducing hepatic fibrosis. Methods for reducing plasma fibrinogen levels.
